Comparative prognostic value of inflammation-based biomarkers for predicting in-hospital mortality in severe acute pancreatitis

Key Points

• To assess the predictive value of inflammation-based biomarkers for in-hospital mortality in severe acute pancreatitis.
• Compared LAR and SOFA scores for predicting mortality.
• Evaluated the effectiveness of LAR as an inflammation-based biomarker.
• Analyzed patient outcomes related to early mortality risk.
• LAR outperformed other biomarkers in predicting early mortality.
• LAR's predictive performance was similar to that of the SOFA score.
• LAR's simplicity enhances its utility for early risk assessment.